ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,308.13
      0.09%
      US Tech 100
      18,178.80
      0.60%
      Dow Jones
      39,806.77
      -0.49%
      Brent Oil
      83.52
      -0.09%
      Bitcoin
      69,284.11
      4.54%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biotech Acquisition Company (BIOT)

      7. Biotech Acquisition Company (BIOT) News

      BIOT

      Biotech Acquisition (BIOT)

      Biotech Acquisition Company
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIOT
      DateTimeSourceHeadlineSymbolCompany
      02/14/20235:02PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:BIOTBiotech Acquisition Company
      02/13/20232:12PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BIOTBiotech Acquisition Company
      02/02/20234:56PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BIOTBiotech Acquisition Company
      02/02/20236:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      01/27/20231:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
      01/25/202312:14PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BIOTBiotech Acquisition Company
      01/11/20239:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      01/04/20235:51PMPR Newswire (US)Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension AmendmentNASDAQ:BIOTBiotech Acquisition Company
      01/04/20233:20PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BIOTBiotech Acquisition Company
      11/22/20226:05AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
      11/14/20221:44PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:BIOTBiotech Acquisition Company
      10/11/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      08/22/20224:06PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BIOTBiotech Acquisition Company
      08/01/20228:00AMBusiness WireBlade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology ConferenceNASDAQ:BIOTBiotech Acquisition Company
      06/17/20224:06PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:BIOTBiotech Acquisition Company
      06/17/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      06/13/20228:06AMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination AgreementNASDAQ:BIOTBiotech Acquisition Company
      06/03/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      06/03/20226:03AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
      06/02/20228:58PMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
      05/31/20228:18AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
      05/31/20228:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      05/31/20227:30AMPR Newswire (US)Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business CombinationNASDAQ:BIOTBiotech Acquisition Company
      05/24/20229:30AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
      05/24/20229:13AMPR Newswire (US)Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.NASDAQ:BIOTBiotech Acquisition Company
      05/23/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      05/19/20224:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
      05/18/20224:21PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:BIOTBiotech Acquisition Company
      05/18/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BIOTBiotech Acquisition Company
      05/18/20229:01AMBusiness WireBlade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International ConferenceNASDAQ:BIOTBiotech Acquisition Company
       Showing the most relevant articles for your search:NASDAQ:BIOT